Facebook
Twitter
LinkedIn
Forward
A Comprehensive Review of the Most Important Presentations from the 2021 San Antonio Breast Cancer Symposium
Please save the date and consider joining us for a review of the most important presentations from the San Antonio Breast Cancer Symposium (SABCS) 2021 Meeting. The meeting is planned to be live and virtual at this time. Updates may be made closer to the event, and more information will follow.
Target Audience
Physicians, researchers, advanced practice providers, nurses, and other health care professionals who work with individuals with breast cancer.
Learning Objectives
• Identify the most up to date findings in breast cancer clinical and translational research.
• Incorporate research findings to appropriately manage patients with breast cancer.
• Demonstrate understanding of the scientific findings in breast cancer research by demonstrating competence in the clinical setting.
Additional Information
| Attachment | Size |
|---|---|
 SABCR Brochure- handout.pdf | 227.76 KB |
8:15 am Welcome - Dhaval Mehta, MD and Shannon Puhalla, MD
8:30 am Triple Negative Breast Cancer Surgery Management of Axilla - Michael Cowher, MD
8:50 am Triple Negative Breast Cancer Update - Leisha Emens, MD, PhD
9:10 am Updates GS2-06/S 3-06 - Kit Lu, MD
9:25 am Questions and Answers - Dhaval Mehta, MD and Shannon Puhalla, MD
9:30 am Targeted Therapy Molecular Profiling/DCIS Genomic Signature/MWRI BioBanking - Adrian Lee, PhD and Steffi Oesterreich, PhD
9:50 am Her2neu and ADC Update - Adam Brufsky, MD
10:20 am Mutation Directed Therapy - Vikram Gorantla, MD
10:40 am Questions and Answers Dhaval Mehta, MD and Shannon Puhalla, MD
11:00 am Break and Vendor Breakout Sessions
11:15 am ER Early-Stage Update - Priya Rastogi, MD
11:35 am Adjuvant Therapy - Terry Evans, MD
11:50 pm Questions and Answers Dhaval Mehta, MD and Shannon Puhalla, MD
12:00 pm CDk4/6 Inhibitor Update - Mohammad Pervaiz Rahman, MD
12:20 pm ER+MBC Novel Agents - Monica Malhotra, MD
12:45 pm Questions and Answers Dhaval Mehta, MD and Shannon Puhalla, MD
1:00 pm Adjournment
The meeting is planned to be virtual at this time.
Adam Brufsky, MD, PhD, FACP
Professor of Medicine
University of Pittsburgh School of Medicine
Associate Division Chief Division of Hematology Oncology
University of Pittsburgh Medicine
Medical Director Magee Womens Cancer Program
UPMC Hillman Cancer Center
Co-Director, Comprehensive Breast Cancer Center
UPMC Magee-Womens Hospital
Michael Cowher, MD
Associate Professor
Breast Surgical Oncology
Director
UPMC Jameson Breast Program
Leisha A. Emens, MD, PhD
Professor of Medicine
UPMC Hillman Cancer Center UPMC Magee-Womens Hospital
Cancer Research Center
Co-Leader, Hillman Cancer Immunology/Immunotherapy Program
Terry L. Evans, MD, FACP
Clinical Assistant Professor of Medicine
University of Pittsburgh School of Medicine
Medical Director of the Arnold Palmer Cancer Center
Vikram Gorantla, MD
Medical Oncology
UPMC Hillman Cancer Center
Adrian V. Lee, PhD
Pittsburgh Foundation Endowed Chair in Precision Medicine
Professor of Pharmacology & Chemical Biology
Director, Institute for Precision Medicine
UPMC Hillman Cancer Center
Kit Lu, MD
Medical Oncology
UPMC Hillman Cancer Center, Central Region
Monica Malhotra, MD
Medical Oncology
UPMC Hillman Cancer Center
Dhaval Mehta, MD
Clinical Assistant Professor
University of Pittsburgh School of Medicine
UPMC Hillman Cancer Center, Monroeville
Steffi Oesterreich, Ph.D.
Shear Family Foundation Chair for Breast
Professor Dept of Pharmacology Cancer Research and Chemical Biology
University of Pittsburgh
Co-Leader Cancer Biology Program
UPMC Hillman Cancer Center
Co-Director Womens Research Institute
Shannon Puhalla, MD
Assistant Professor of Medicine
University of Pittsburgh School of Medicine
UPMC Hillman Cancer Center
UPMC Passavant
UPMC Magee-Women's Hospital
Mohammad Pervaiz Rahman, MD
Medical Oncology
UPMC Hillman Cancer Center, Steubenville
Priya Rastogi, MD
Senior Associate Medical Director
NSABP Medical Affairs
Associate Professor of Medicine
University of Pittsburgh School of Medicine
UPMC Hillman Cancer Center
Faculty Disclosure:
All individuals in a position to control the content of this education activity including members of the planning committee, speakers, presenters, authors, and/or content reviewers have disclosed all relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients.
The following relevant financial relationships were disclosed:
• Adrian Lee, PhD – Grant/Research Support: AstraZeneca, Puma Biotechnology
• Kit Lu, MD – Consultant: Pfizer, Daiichi Sankyo, AstraZeneca, Macrogenics; Biotheranostics; CE Speaker's Bureau: Daiichi Sankyo, AstraZeneca, Seattle Genetics
• Steffi Oesterreich, PhD – Grant Research Support: AstraZeneca, Puma Biotechnology
• Adam Brufsky, MD, PhD – Consultant: Roche, Puma, Seattle Genetics, AstraZeneca, Daiichi Sankyo, Pfizer, Novartis
• Dhaval R Mehta, MD – Consultant: AstraZeneca
• Shannon Puhalla, MD – Grant/Research Support: AbbVie, Pfizer, Lilly, Novartis, Incyte, Covariance-Bayer, AstraZeneca. Consultant: AbbVie, MedImmune, Celldex, Puma, Pfizer, AstraZeneca, Esai, nanostring
• Leisha A. Emens, MD, PhD – Grant/Research Support: AbbVie, AstraZeneca, Bolt Therapeutics, Bristol Meyer Squibb, Compugen, CytomX, Corvus, EMD Serono; Genentech, F Hoffman La Roche, Immune Onc, Merck, Next Cure, Silverback, Takeda, Tempest. Consultant: Genentech, F Hoffman La Roche, Chugai, GCPR, Gilead, Immune Onc, Abbvie, Shionogi, Mersana
No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
Accreditation and Credit Designation
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician (CME)
The University of Pittsburgh designates this live activity for a maximum of 4.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing (CNE)
The maximum number of hours awarded for this Continuing Nursing Education activity is 4.5 contact hours.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Available Credit
- 4.50 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 4.50 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
- 4.50 Attendance
We gratefully acknowledge support from the following exhibitors for this activity:
- Agendia, Inc.
- AstraZeneca
- Daiichi Sankyo, Inc.
- Eisai
- Genentech A Member of the Roche Group
- Lilly Oncology
- Merck & Co. Inc
- Novartis
- Seagen
Price
Registration categories and fees:
non-UPMC Physicians ($75)
non-UPMC medical professionals ($50)
UPMC Physicians and medical professionals ($0)
For more information, contact Becky McClelland at mcclellandr2@upmc.edu.
All cancellations must be sent via email, [mcclellandr2@upmc.edu]. Cancellations received before [02/12/2022] will be refunded in full. After 02/13/2022 no refunds will be made.
Participation by all individuals is encouraged. Advance notification of any special needs will help us provide better service. Please notify us of your needs at least two weeks in advance of the program by emailing mcclellandr2@upmc.edu.